Companies on Diabetes and Endocrinology

Published within

« | 1 | 2 | 3 | » »|

Type Product title / description Pub Price
Company Profile
Company Profile

Ipsen S.A.

Ipsen (or 'the group') is a global biopharmaceutical group with products in targeted therapeutic areas such as oncology, endocrinology, neurology, and primary care. The group primarily operates in Europe and North America. It is headquartered in Boulogne-Billancourt, France, and employed 4,602 people as of December 31, 2013.

Published By MarketLine
07 Oct 2014 $175
Buy
Company Profile
Company Profile

CJ CheilJedang Corp.

CJ CheilJedang Corp. (CJ CheilJedang or 'the company') is engaged in providing food; bioscience-based products; and feed and livestock products. The company operates in Asia, Australia, the US, Germany and Brazil. It is headquartered in Jung-gu, South Korea.

Published By MarketLine
10 Oct 2014 $175
Buy
Company Profile
Company Profile

Merck KGaA

Merck KGaA (or 'the group') is a leading company for high-tech products in the pharmaceutical and chemical sectors. The Merck family holds an approximately 70% interest in the group. Merck KGaA operates in 66 countries across the world. It is headquartered in Darmstadt, Germany, and employed 38,154 people as of December 31, 2013.

Published By MarketLine
29 Oct 2014 $175
Buy
Company Profile
Company Profile

Depomed, Inc.

Depomed, Inc. (Depomed or 'the company') is a specialty pharmaceutical company focused on the development and commercialization of differentiated products that are based on oral drug delivery technologies. The company primarily operates in the US. Depomed is headquartered in Menlo Park, California, and employed 308 people as of March 14, 2014.

Published By MarketLine
29 Oct 2014 $175
Buy
Company Profile
Company Profile

Shire plc

Shire (or 'the company') is a specialty biopharmaceutical company primarily operating in North America and Europe. It is headquartered in Dublin, Republic of Ireland, and employed 5,338 people as of December 31, 2013.

Published By MarketLine
07 Nov 2014 $175
Buy
Company Profile
Company Profile

Isis Pharmaceuticals, Inc.

Isis Pharmaceuticals (Isis or 'the company') uses antisense technology, a drug discovery platform, to discover and develop novel drugs for its product pipeline and also for its partners. The company primarily operates in the US. It is headquartered in Carlsbad, California, and employed 304 people as of February 17, 2014.

Published By MarketLine
04 Dec 2014 $175
Buy
Company Profile
Company Profile

Novartis AG

Novartis (or 'the company') is one of the Big Pharma companies having strong presence in diverse biopharmaceutical segments. It is engaged in the research, development, manufacture and marketing of branded drugs, generic pharmaceutical products, preventive vaccines, diagnostic tools and consumer health products. The company operates in more than 150 countries. It is headquartered in Basel, Switzerland, and employed 135,696 people as of December 31, 2013.

Published By MarketLine
15 Dec 2014 $175
Buy
Company Profile
Company Profile

Pfizer Inc.

Pfizer (or 'the company') is a research-based, global biopharmaceutical company. Its portfolio includes medicines, vaccines and consumer products. The company operates in several countries across the globe. It is headquartered in New York City, New York, and employed 77,700 people as on December 31, 2013.

Published By MarketLine
22 Dec 2014 $175
Buy
Company Profile
Company Profile

BioMarin Pharmaceutical Inc.

BioMarin Pharmaceutical (BioMarin or 'the company'), a commercial-stage biopharmaceutical company, develops and commercializes biopharmaceuticals for the treatment of serious diseases and medical conditions. The company operates in the US, Europe and Latin America. It is headquartered in San Rafael, California, and employed 1,341 people as of January 24, 2014.

Published By MarketLine
24 Dec 2014 $175
Buy
Company Profile
Company Profile

Amgen, Inc.

Amgen (or 'the company') is a leading biotechnology company engaged in the discovery, development, manufacture, and marketing of innovative human therapeutics. The company mainly focuses in the areas of cancer, kidney disease, rheumatoid arthritis and other serious illnesses. It primarily operates in the US where it is headquartered in Thousand Oaks, California. Amgen employed about 20,000 people as of December 31, 2013.

Published By MarketLine
23 Jan 2015 $175
Buy

« | 1 | 2 | 3 | » »|

No help is available.